Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Signum Life Science ApS
APS
Active
CVR 36559241
Lersø Parkallé 101, 2100
København Ø
Computer consultancy and computer facilities management activities
·
NACE 6220
Est. 2015 · 11 years old
48 employees
Monitor
Share
Denmark
/
Companies
/
Computer consultancy and computer facilities management activities
/
Signum Life Science ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
32M
1M
-30M
-60M
-91M
2021: 8M
8M
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 1M
1M
2023
2024: -2M (-300% vs 2023)
-2M
-300%
2024
2025: -67M (-3250% vs 2024)
-67M
-3250%
2025
EBITDA
DKK millions
26M
-6M
-37M
-68M
-100M
2021: 1M
1M
2021
2022: -7M (-800% vs 2021)
-7M
-800%
2022
2023: -6M (+14% vs 2022)
-6M
+14%
2023
2024: -9M (-50% vs 2023)
-9M
-50%
2024
2025: -75M (-733% vs 2024)
-75M
-733%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
-67.441
-1.866
1.482
-184
7.602
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-75.077
-8.847
-5.640
-7.091
941
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-75.077
-8.847
-5.640
-7.091
941
Net financials
552
2.343
2.787
-6.311
1.846
Profit before tax
-74.525
-6.503
-2.853
-13.403
2.787
Tax
-8.475
-566
231
-2.089
1.470
Net profit
-66.050
-5.937
-3.084
-11.313
1.317
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
56.661
125.590
131.454
133.491
150.970
Equity
40.681
106.811
112.748
115.832
128.463
Long-term debt
0
0
0
0
0
Short-term debt
15.981
14.028
13.415
12.168
15.232
Total debt
15.981
14.028
13.415
12.168
15.232
Financial ratios
5-year trend
EBITDA margin (of gross profit)
<−999 %
This company
2021
2025
Equity ratio
71,8 %
This company
38,2 %
Market median
This company
Market median
88% above market
2021
2025
Return on equity
-162,4 %
This company
18,4 %
Market median
This company
Market median
983% below market
2021
2025
Net profit margin (of gross profit)
<−999 %
This company
2021
2025
Asset turnover (of gross profit)
-1,19×
This company
2021
2025
Debt / equity
0,39×
This company
0,62×
Market median
This company
Market median
37% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Signum Life Science ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
